WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market. Currently, all COVID-19 treatments used in the U.S. ...
Yol, Haberleri, Trafik
Merkez mahallesi mutlu han sokak no:17/2 Bartın/Sakarya
info@theinternet.com.tr